Preferred Label : tyrosinemias;
MeSH definition : A group of disorders which have in common elevations of tyrosine in the blood and
urine secondary to an enzyme deficiency. Type I tyrosinemia features episodic weakness,
self-mutilation, hepatic necrosis, renal tubular injury, and seizures and is caused
by a deficiency of the enzyme fumarylacetoacetase. Type II tyrosinemia features INTELLECTUAL
DISABILITY, painful corneal ulcers, and keratoses of the palms and plantar surfaces
and is caused by a deficiency of the enzyme TYROSINE TRANSAMINASE. Type III tyrosinemia
features INTELLECTUAL DISABILITY and is caused by a deficiency of the enzyme 4-HYDROXYPHENYLPYRUVATE
DIOXYGENASE. (Menkes, Textbook of Child Neurology, 5th ed, pp42-3);
MeSH synonym : tyrosinemia; tyrosinemia, hereditary; tyrosinemias, hereditary; hereditary tyrosinemia; hereditary tyrosinemias; hypertyrosinemia;
CISMeF synonym : 2 tyrosinemia, type;
MeSH hyponym : tyrosinemia, type III; tyrosinemia, type II; tyrosinemia, type I; Type III Tyrosinemia; Type III Tyrosinemias; Tyrosinemias, Type III; Deficiency Disease, 4-Hydroxyphenol Pyruvic Acid Oxidase; Deficiency Disease, 4 Hydroxyphenol Pyruvic Acid Oxidase; 4-Hydroxyphenylpyruvate Dioxygenase Deficiency; Deficiencies, 4-Hydroxyphenylpyruvate Dioxygenase; Deficiency, 4-Hydroxyphenylpyruvate Dioxygenase; Dioxygenase Deficiencies, 4-Hydroxyphenylpyruvate; Dioxygenase Deficiency, 4-Hydroxyphenylpyruvate; 4-Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease; 4 Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease; 4-Hydroxyphenylpyruvic Acid Oxidase Deficiency; 4 Hydroxyphenylpyruvate Dioxygenase Deficiency Disease; Hereditary Tyrosinemia, Type III; Type I Tyrosinemia; Type I Tyrosinemias; Tyrosinemias, Type I; Fumarylacetoacetase Deficiency Disease; Fumarylacetoacetase Deficiency; Deficiencies, Fumarylacetoacetase; Deficiency, Fumarylacetoacetase; Fumarylacetoacetase Deficiencies; Hypertyrosinemia, Type I; Hypertyrosinemias, Type I; Type I Hypertyrosinemia; Type I Hypertyrosinemias; Tyrosinemia Type 1; Tyrosinemia Type 1s; Hepatorenal Tyrosinemia; Hepatorenal Tyrosinemias; Tyrosinemia, Hepatorenal; Tyrosinemias, Hepatorenal; Hereditary Tyrosinemia, Type I; Deficiency Disease, Fumarylacetoacetase; Deficiency Diseases, Fumarylacetoacetase; Disease, Fumarylacetoacetase Deficiency; Diseases, Fumarylacetoacetase Deficiency; Fumarylacetoacetase Deficiency Diseases; Type II Tyrosinemia; Type II Tyrosinemias; Tyrosinemias, Type II; Deficiency Disease, Tyrosine Transaminase; Hereditary Tyrosinemia, Type II; Richner-Hanhart Syndrome; Richner Hanhart Syndrome; Richner-Hanhart Syndromes; Syndrome, Richner-Hanhart; Syndromes, Richner-Hanhart; Tat Deficiency; Deficiencies, Tat; Deficiency, Tat; Tat Deficiencies; Tyrosinemia, Type 2; 2 Tyrosinemias, Type; Type 2 Tyrosinemia; Type 2 Tyrosinemias; Tyrosinemias, Type 2; Tyrosine Transaminase Deficiency; Keratosis Palmoplantaris with Corneal Dystrophy; Oregon Type Tyrosinemia; Richner-Hanhart Syndrome, Tyrosinosis, Oculocutaneous Type; Tyrosine Aminotransferase Deficiency; Tyrosine Transaminase Deficiency Disease; Tyrosinosis, Oculocutaneous Type; Oculocutaneous Type Tyrosinoses; Oculocutaneous Type Tyrosinosis; Type Tyrosinoses, Oculocutaneous; Type Tyrosinosis, Oculocutaneous; Tyrosinoses, Oculocutaneous Type;
MeSH annotation : note X refs: consider also TYROSINE TRANSAMINASE /defic or other enzymes /defic;
Wikipedia link : https://en.wikipedia.org/wiki/Tyrosinemia;
Origin ID : D020176;
UMLS CUI : C0268486;
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Has phenotype(s) (HPO)
Manual BTNT mappings - CISMeF
Manual NTBT mappings (CISMeF)
Record concept(s)
Related MeSH Supplementary Concept(s)
See also
See also (suggested by CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A group of disorders which have in common elevations of tyrosine in the blood and
urine secondary to an enzyme deficiency. Type I tyrosinemia features episodic weakness,
self-mutilation, hepatic necrosis, renal tubular injury, and seizures and is caused
by a deficiency of the enzyme fumarylacetoacetase. Type II tyrosinemia features INTELLECTUAL
DISABILITY, painful corneal ulcers, and keratoses of the palms and plantar surfaces
and is caused by a deficiency of the enzyme TYROSINE TRANSAMINASE. Type III tyrosinemia
features INTELLECTUAL DISABILITY and is caused by a deficiency of the enzyme 4-HYDROXYPHENYLPYRUVATE
DIOXYGENASE. (Menkes, Textbook of Child Neurology, 5th ed, pp42-3)
https://www.has-sante.fr/jcms/p_3375540/fr/tyrosinemie-type-1-ht-1
2022
France
practice guideline
Tyrosinemia
tyrosinemias
Diseases
Handbook
Chronic disease
chronic disease, nos
chronic disease
---
https://www.anses.fr/fr/system/files/NUT2021SA0141.pdf
2022
France
technical report
amino acids
amino acid, nos
inlets
Metabolic diseases
bays
patients
tyrosinemias
Amino acid
patient need for
Tyrosinemia
snacks
has assessment
specialists
emigration and immigration
nutritional requirements
needs
nutritional requirement
evaluation studies as topic
Metabolic diseases
metabolic diseases
Diseases
judgment
Metabolic diseases
specialization
metabolic disease, nos
---
http://www.coramh.org/
Canada
French
English
ataxia
ataxia
ataxia
signs and symptoms
genetic counseling
cystic fibrosis
cystic fibrosis
cystic fibrosis
cystic fibrosis
hereditary sensory and motor neuropathy
hereditary sensory and motor neuropathy
hereditary sensory and motor neuropathy
acidosis, lactic
acidosis, lactic
acidosis, lactic
tyrosinemias
tyrosinemias
tyrosinemias
tyrosinemias
myotonic dystrophy
myotonic dystrophy
myotonic dystrophy
hyperlipoproteinemia type ii
hyperlipoproteinemia type ii
hyperlipoproteinemia type ii
hyperlipoproteinemia type ii
quebec
genetic diseases, inborn
rare diseases
genetic diseases, inborn
association of patients
---
http://www.tousalecole.fr/content/tyrosin%C3%A9mie-de-type-i
2011
true
France
French
schools
Mainstreaming, Education
child
adolescent
tyrosinemias
popular works
Tyrosinemia type 1
---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=69723
2010
false
true
false
France
tyrosinemia, type III
scientific and technical information
tyrosinemias
---
http://www.anses.fr/sites/default/files/documents/NUT2009sa0076.pdf
2009
France
French
tyrosinemias
infant
child
corneal diseases
keratoderma, palmoplantar
tyrosinemia, type II
health technology assessment
treatment outcome
---
http://www.anses.fr/sites/default/files/documents/NUT2008sa0373.pdf
2009
France
French
tyrosinemias
health technology assessment
treatment outcome
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/la-spectrometrie-de-masse-en-tandem-et-le-depistage-neonatal-sanguin-au-quebec.html
2007
false
Canada
French
neonatal screening
tandem mass spectrometry
phenylketonurias
infant, newborn
canada
tyrosinemias
congenital hypothyroidism
review literature as topic
neonatal screening
mass spectrometry
neonatal screening
hematologic tests
health technology assessment
table
comparative study
---
https://www.inspq.qc.ca/sites/default/files/publications/484-rapportdepistagesanguin.pdf
2006
Canada
French
mass screening
infant, newborn
genetic diseases, inborn
canada
blood chemical analysis
phenylketonurias
congenital hypothyroidism
tyrosinemias
program evaluation
public health evaluation
algorithms
table
bibliography
questionnaires
---